Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $7.47M | $7.41M | +0.81% |
Operating Income | $-119.29M | $-104.13M | -14.55% |
Net Income | $-109.27M | $-98.67M | -10.74% |
EPS (Basic) | $-1.24 | $-1.21 | -2.48% |
EPS (Diluted) | $-1.24 | $-1.21 | -2.48% |
R&D Expense | $98.82M | $84.82M | +16.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.47B | $1.36B | +7.88% |
Current Assets | $1.25B | $1.12B | +11.22% |
Total Liabilities | $343.78M | $446.31M | -22.97% |
Current Liabilities | $141.55M | $187.22M | -24.40% |
Stockholders' Equity | $1.12B | $913.49M | +22.95% |
Cash & Equivalents | $527.91M | $287.85M | +83.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-103.88M | $-99.75M | -4.15% |
Investing Cash Flow | $-125.09M | $-53.46M | -133.97% |
Financing Cash Flow | $473.38M | $2.9M | +16240.32% |
D&A | $5.53M | $5.43M | +1.79% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1596.9% | -1405.3% | -191.58% |
Net Margin | -1462.8% | — | — |
ROE | -9.7% | — | — |
ROA | -7.4% | — | — |
Current Ratio | $8.814 | — | — |
Debt to Equity | $0.306 | — | — |
Other companies in Biotechnology